Fosrenol (Avera McKennan Hospital)


Welcome to the PulseAid listing for the Fosrenol drug offered from Avera McKennan Hospital. This Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Avera McKennan Hospital
NON-PROPRIETARY NAME: lanthanum carbonate
SUBSTANCE NAME: LANTHANUM CARBONATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Phosphate Binder [EPC],Phosphate Chelating Activity [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, CHEWABLE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-03-03
END MARKETING DATE: 0000-00-00


Fosrenol HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFosrenol from Avera McKennan Hospital
LABELER NAME: Avera McKennan Hospital
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/1)
START MARKETING DATE: 2015-03-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69189-0252_97491ceb-a454-4419-ac85-1bd29d4c5a7f
PRODUCT NDC: 69189-0252
APPLICATION NUMBER: NDA021468

Other LANTHANUM CARBONATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalFosrenol
Cardinal HealthFosrenol
Lupin Pharmaceuticals, Inc.Lanthanum Carbonate
Prasco LaboratoriesLanthanum carbonate
Shire US Manufacturing Inc.Fosrenol